Comparison of CWD and ICW tympanomastoidectomy with endoscopic control to evaluate residual cholesteatoma for patients with middle and mastoid cholesteatoma
Phase 3
- Conditions
- Tympanomastoidectomy in people with cholesteatoma.Cholesteatoma of middle ear
- Registration Number
- IRCT20191123045472N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients who were diagnosed with microscopic examination of cholesteatoma and who were candidates for surgery, with any hearing loss
Exclusion Criteria
Patient with cholesteatoma with posterior wall destruction
The patient does not follow-up or postoperative follow-up examinations for any reason.
The patient has complications of cholesteatoma, such as dizziness, facial paralysis, sensorineural hearing loss average or above average, intracranial complications, mastoid abscess, lateral sinus thrombosis, etc
The patient should be treated with revision
Failure after graft surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of remaining cholesteatoma. Timepoint: 3 months, 6 months, 9 months and 12 months. Method of measurement: Endoscope 30 ° and 7.2 mm.
- Secondary Outcome Measures
Name Time Method